Weight loss medications that have been tested and approved through regulatory pathways are safe and effective for individuals experiencing indications such as obesity, diabetes, MASH, obstructive sleep apnea, and in some cases heart disease, says Dr
Reema Arora helps determine whether IV infusion therapy is suitable for you, and if so, which protocol is safest and most appropriate for your goals
First, it allows your GLP-1 receptors to begin upregulating in response to the agonist
Mounjaro also became available on the NHS for weight management in June 2025, though access remains highly restricted and is reserved for individuals with the greatest clinical need
Individuals with risk factors like high triglycerides may be more vulnerable